A sudden release of many pigment granules into the aqueous might be expected to produce a measurable increase in intraocular pressure and a decrease in facility of outflow. Experiments designed to test this have been published12 and confirm a notion that seems entirely reasonable. However, when phenylephrine-induced pigment release is used as an experimental model in human eyes, no consistent response pattern develops. Kristensen3 recorded a pressure increase in patients with pigmentary and exfoliation glaucoma, but Aggarwal and if pigment is trapped at the uveal level, then the effect would be of little consequence. Consequently eyes with a normal outflow system may be unable to demonstrate a pigment-induced pressure increase.
Thirdly, intraocular pressure is inversely proportional to facility of outflow. Therefore, for a given absolute decrease in facility of outflow the resulting increase in intraocular pressure will be greater if the initial facility of outflow is low. This means that if an eye already has outflow damage it is more likely to demonstrate a pigment-release effect.
This paper describes the result of experiments designed to test these aspects of pigment release.
Material and methods
The basic experiment was divided into 3 stages. Stage 1. At the start intraocular pressure, facility of outflow, and pupil diameter were measured. Gonioscopy was done and iridocorneal contact sought in the 4 quadrants. One drop of the drug (or drugs) was instilled into the right eye or, if the ocular hypertension or glaucoma was left-sided, then into that eye. Finally, the presence or absence of pigment granules in the aqueous was noted. first dose of phenylephrine pressure decreased a mean of 24-1 to a mean of 22-9 mmHg (t= not significant); outflow increased from a me 0-13 to a mean of 0-16 (t=1-28, not signifi After the second dose pressure increased fr mean of 22-9 to a mean of 26 5 mmHg (t= 1-8' significant); outflow decreased from a mean or to a mean of 0-11 (t=2-43, not significant). 0 there was no significant change in either presst outflow (for pressure t= 1-3; for outflow t= 1 -' Experiment 4: Pilocarpine 20% and phenylej 100% instilled (a) Sixty-six eyes with untreated ocular hyperter (i) No pigment released-40 eyes (Fig. 2) . Aftc first dose pressure decreased from a mean of 2ã mean of 21-1 mmHg (t=7-7, p<0-001); ou increased from a mean of 0-17 to a mean of (t=7-35, p<0-001). After the second dose pre decreased from a mean of 21 1 to a mea 19 9 mmHg (t=2-89, p <0-01); outflow incri from a mean of 0-25 to a mean of 0-29 (t= p<0-01). Overall, pressure decreased and ou increased by a significant amount (for pre t=8-65, p<0-001; for outflow t=8-59, p<0
(ii) Pigment released-26 eyes (Fig. 2) . Afte first dose pressure decreased from a mean of 22 a mean of 21-6mmHg (t=3-9, p<0-001); ou increased from a mean of 0-16 to a mean of (t=1 8, not significant). After the second pressure increased from a mean of 21 (Fig. 3) .
After the first dose pressure decreased from a mean -of 24-6 to a mean of 18 7 mmHg (t=4-8, p<0-001); outflow increased from a mean of 0 15 to a mean of 0-21 (t=4-96, p <0 001). After the second dose pressure decreased from a mean of 18-7 to a mean of 17-4 mmHg (t= 1 62, not significant); outflow increased from a mean of 0-21 to a mean of 0-23 (t= 1-4, not significant). Overall, pressure decreased and outflow increased by a significant amount (for pressure t=5 18, p<0-001; for outflow t=4 47, Ip <0-001). 2 (ii) Pigment released-30 eyes (Fig. 3) . After the first dose pressure decreased from a mean of 23-5 o°to a mean of 22-8 mmHg (t=0-87, not significant);
outflow remained unchanged at 0-13. After the second dose pressure increased from a mean of 22-8 to a mean of 25-2mmHg (t=3-26, p<0-001); outflow was again unchanged at a mean of 0-13. from Overall there was no significant change in either 1-49, pressure or outflow (for pressure t=1 62; for an of outflow t=0 56). cant).
om a Experiment 5: pilocarpine 2% and phenylephrine 7, not 10% instilled into 21 eyes with treated exfoliation f 0-16 glaucoma (Fig. 4 of 19 to a mean of 20 6 mmHg (t=1-31, not significant); outflow decreased from a mean of 0-13 to a mean of 0-11 (t=1-53, not significant). After the second dose pressure increased from a mean of to a mean of 23 Phenylephrine acts by direct stimulation of alpha adrenoreceptors.10 Clonidine-an alpha agonisthas no effect on facility of outflow in monkeys," but in the isolated perfused cat eye it causes a decrease in aqueous production.'2 Adrenaline,'3 salbutamol,'4 and isoprenaline13 all increase facility of outflow-a consequence of beta agonist activity. Sears'5 and Sears and Neufeld'6 suggest that the effects of alpha agonist activity may be 2-fold. Firstly, receptor stimulation may constrict blood vessels supplying the ciliary body, reducing the quantity of ultrafiltrate presented to the ciliary epithelium. This will appear tonographically as an increase in C total-although in reality a pseudofacility. Secondly, effects on the external eye may cause arteriolar constriction, reduce episcleral venous pressure, and produce a slight increase in outflow. There is therefore no experimental evidence to suggest that pilocarpine and phenylephrine, singly or in combination, will have any effect in normal or ocular hypertensive eyes other than to increase total facility of outflow and decrease intraocular pressure.
The results show that, in a group of eyes with ocular hypertension, spontaneous change in outflow and pressure during a 2j-hour period was not statistically significant. Pilocarpine alone and phenylephrine alone (in the absence of pigment release) both produced a significant decrease in pressure and increase in facility of outflow. Similar results were obtained (in the absence of pigment release) after instilling pilocarpine and phenylephrine simultaneously into eyes with ocular hypertension or open-angle glaucoma.
However, if the instilled drugs also release much pigment into the aqueous, then in neither group of eyes does a significant change in outflow or pressure occur. The reasonable inference is therefore that pigment has mechanically blocked the outflow channels and prevented the pressure decrease and outflow increase that occur in the absence of pigment.
There is no reason to suppose that pigment release will have any direct effect on aqueous inflow, so that any pseudofacility effect will remain the same, whether or not pigment is released. It is concluded therefore that pigment release does cause a mechanical block and prevents the outflow increasing effect of autonomic drugs.
No one group showed a significant decrease in facility of outflow. To demonstrate that this can happen 2 groups of eyes were chosen. One, with exfoliation glaucoma, showed a significant increase in pressure and decrease in outflow. The other showed a paradoxical response to a provocative test with pilocarpine and phenylephrine. In spite of open angles pressure increased by 14 mmHg, and outflow decreased. Both groups showed a large release of pigment.
One major determinant of these observations is to be found in the inverse relationship between pressure and outflow. The basic Goldman equation is PO = (F/C) + P, where PO = intraocular pressure (mmHg), F = aqueous inflow (,ul/min), C = facility of outflow (,d/min/mmHg), P, = episcieral venous pressure (mmHg).
Assume inflow constant at 1 5 ,ul/min and episcleral venous pressure also constant at 10 mmHg. If an eye has a facility of outflow of 0-21, intraocular pressure is 17-1 mmHg. If outflow is decreased to 0 16, pressure increases to 19-4 mmHg.
On the other hand, if outflow is initially 0-11 and decreases to 0-06, then pressure increases to 35 mmHg. That is, a change in outflow when the initiat facility is high will have a lesser effect on pressure than a numerically identical change at low facilities of outflow. This was the reason for studying patients with aging or damaged outflow systems in this paper.
CLINICAL IMPLICATIONS
The fact that phenylephrine alone, or in combination with pilocarpine, can release much pigment and produce large pressure increases is at first sight of little clinical significance. But there are various situations in which it is of significance.
Firstly, any statements concerning the effects of autonomic drugs on intraocular pressure and facility of outflow are of limited value unless the presence or absence of pigment release is also noted. This means that provocative tests involving pupil movement must take into account the effect of pigment, as also should reports of anomalous pressure changes after phenylephrine instillation. '7 18 Secondly, one drug combination used in the treatment of open-angle glaucoma, namely, pilocarpine and adrenaline, can cause a shower of pigment to appear and produce a paradoxical increase in pressure and decrease in outflow. For example, a man with exfoliation glaucoma was being treated with guttae pilocarpine 4% and guttae timolol maleate 05%. The effect of pilocarpine 2% and adrenaline 1 % was to increase pressure from 20 to 28 mmHg and decrease outflow from 0-08 to 0 05. A shower of pigment was released and was, presumably, the cause of the change.
Thirdly, there is evidence that pigment can be released spontaneously in large quantities. Epstein et al.6 described 2 patients, in one of whom blurred vision and haloes appeared after exercise, Direct provocation (jogging for 2 hours) reproduced the symptoms together with an increased pressure, decreased outflow, and much pigment release. In the other patient dim illumination and emotional crises produced symptoms. During a spontaneous attack, which occurred after working outside in dim illumination, intraocular pressure was 55 mmHg in the right eye together with much pigment in the aqueous.
Schenker et al. 19 also described a patient in whom blurred vision and haloes appeared after exercise, emotional stress, and dim illumination. A darkroom provocative test and exercise both reproduced symptoms, together with an increased pressure and pigment release. They tried the effect of pilocarpine on the pigment-releasing effect of exercise and suggested that, because symptoms were no longer produced, it is possible to nullify the effect of pigment on pressure. However, the results described above suggest that this is not generally so.
From the association between stress or dim illumination and pigment release Schenker et al. 19 infer that the cause is mechanical abrasion of pigment epithelium produced by pupillary movement. The results (Tables 1 and 2) show that while these conditions are necessary they are not sufficient, for the reason that phenylephrine produced a significant increase in pupil diameter in all eyes but pigment appeared in some only. When the effects of combined pilocarpine and phenylephrine are considered, it is apparent that pigment release is associated with significant changes in pupil diameter, whereas, if no change occurred, no pigment appeared. It therefore follows that, while pupillary movement and mechanical abrasion were necessary for pigment release to occur, their combined presence was not a sufficient condition.
Whatever the mechanism of pigment release may be, it is apparent that it can occur in sufficient quantities to produce a substantial increase in pressure. The outflow damage that is known to follow pigment release20 21 together with the observations described above provide a sufficient explanation for glaucoma associated with pigment release.
